RT Journal Article
SR Electronic
T1 COVID-19 Vaccine Uptake among U.S. Child Care Providers
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.30.21261383
DO 10.1101/2021.07.30.21261383
A1 Patel, Kavin M.
A1 Malik, Amyn A.
A1 Lee, Aiden
A1 Klotz, Madeline
A1 Humphries, John Eric
A1 Murray, Thomas
A1 Wilkinson, David
A1 Shafiq, Mehr
A1 Yildirim, Inci
A1 Elharake, Jad A.
A1 Diaz, Rachel
A1 Reyes, Chin
A1 Omer, Saad B.
A1 Gilliam, Walter S.
YR 2021
UL http://medrxiv.org/content/early/2021/08/01/2021.07.30.21261383.abstract
AB Objectives Ensuring a high COVID-19 vaccine uptake among U.S. child care providers is crucial to mitigating the public health implications of child-to-staff and staff-to-child transmission of SARS-CoV-2; however, the vaccination rate among this group is unknown.Methods To characterize the vaccine uptake among U.S. child care providers, we conducted a cross-sectional survey of the child care workforce. Providers were identified through various national databases and state registries. A link to the survey was sent via email between May 26 and June 23, 2021. Out of 44,771 potential respondents, 21,663 responded (48.4%).Results Overall COVID-19 vaccine uptake among U.S. child care providers (78.1%, 95% CI [77.3% to 78.9%]) was higher than that of the U.S. adult population (65%). Vaccination rates varied from 53.5% to 89.4% between states. Vaccine uptake differed significantly (p < .01) based on respondent age (70.0% for ages 25-34, 91.5% for ages 75-84), race (70.0% for Black or African Americans, 92.5% for Asian-Americans), annual household income (70.7% for <$35,000, 85.0% for>$75,000), and childcare setting (72.9% for home-based, 79.7% for center-based).Conclusions COVID-19 vaccine uptake among U.S. child care providers was higher than that of the general U.S. adult population. Those who were younger, lower income, Black or African American, resided in states either in the Mountain West or the South, and/or worked in home-based childcare programs reported the lowest rates of vaccination; state public health leaders and lawmakers should prioritize these subgroups for placement on the policy agenda to realize the largest gains in vaccine uptake among providers.Tables of Contents Summary This article describes the results of a national survey of childcare providers to determine the overall COVID-19 vaccine uptake and the gaps in vaccine coverage.What’s Known on This Subject Ensuring a high COVID-19 vaccine uptake among U.S. child care providers is crucial to mitigating the public health implications of child-to-staff and staff-to-child transmission of SARS-CoV-2; however, the vaccination rate among this group is unknown.What This Study Adds While the vaccine uptake among U.S. child care providers was higher than that of U.S. adults, certain subgroups continue to warrant focused attention for outreach and/or placement on the policy agenda.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by The Andrew & Julie Klingenstein Family Fund, Esther A. & Joseph Klingenstein Fund, Heising-Simons Foundation, W.K. Kellogg Foundation, Foundation for Child Development, Early Educator Investment Collaborative, Scholastic Inc, Yale Institute for Global Health, and Tobin Center for Economic Policy at Yale University. Invaluable assistance with obtaining child care provider contact information was provided by the National Workforce Registry Alliance (and its network of state child care workforce registries), Child Care Aware of America, and National Association for the Education of Young Children. Drs. Amalia Londono Tobon and Adrian Cerezo Caballero provided Spanish translations and back translations of the survey measures and recruitment information. Alicia Alonso, Catherine Chang, Renee Dauerman, Stella FitzGerald, Harleen Kaur, Emma Knight, and Helen Mooney provided assistance in qualitative data categorization of respondent comments.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The research protocol was approved by the Yale University Institutional Review Board (IRB protocol number: 2000028232).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A